fluorodeoxyglucose f18 has been researched along with Parkinson Disease, Secondary in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, P; Li, Y; Ren, HB; Wang, W; Zhang, SZ; Zhang, ZJ | 1 |
| Bhidayasiri, R; Chotipanich, C; Johansson, J; Joutsa, J; Juiklom, W; Rinne, JO; Tepmongkol, S; Wannachai, N | 1 |
| Apaydin, H; Karaoglan, O; Sarikaya, I; Topal, U | 1 |
| Jeong, Y; Lee, JH; Lee, MS; Lee, SY; Lyoo, CH; Rinne, JO; Ryu, YH; Song, TJ | 1 |
| Lang, AE | 1 |
| Calne, DB; Doudet, D; Hewitt, KA; Nugent, R; Olanow, W; Pate, BD; Perl, DP; Shinotoh, H; Snow, BJ | 1 |
| Antonini, A; Dhawan, V; Eidelberg, D; Feigin, A; Kazumata, K; Mandel, F; Margouleff, C | 1 |
| Barlogie, B; Dhodapkar, M; Eidelberg, D; Harik, SI; Rudnicki, SA | 1 |
| Cederbaum, J; Dhawan, V; Eidelberg, D; Fahn, S; Ginos, JZ; Greene, P; Moeller, JR; Powers, JM; Sidtis, JJ; Strother, SC | 1 |
| Adam, MJ; Calne, DB; Grierson, JR; Martin, WR; Palmer, M; Pate, BD; Ruth, TJ; Stoessl, AJ | 1 |
| Hanson, WR; Metter, EJ | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed | 1995 |
10 other study(ies) available for fluorodeoxyglucose f18 and Parkinson Disease, Secondary
| Article | Year |
|---|---|
[Changes of glucose in the brains of monkeys with MPTP induced Parkinson's disease].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Haplorhini; Male; Parkinson Disease, Secondary; Positron-Emission Tomography | 2013 |
Boxing and Parkinson disease: a link or a myth? An 18F-FDOPA PET/CT study in retired Thai traditional boxers.
Topics: Aged; Boxing; Brain Injury, Chronic; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Parkinson Disease, Secondary; Positron-Emission Tomography; Severity of Illness Index; Thailand; Tomography, X-Ray Computed | 2012 |
Cyanide-induced parkinsonism and F-18 FDG PET/CT findings.
Topics: Adult; Cyanides; Fluorodeoxyglucose F18; Humans; Male; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Suicide, Attempted; Tomography, X-Ray Computed | 2006 |
Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
Topics: Aged; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2008 |
MRI and PET studies of manganese-intoxicated monkeys.
Topics: Animals; Carbidopa; Corpus Striatum; Deoxyglucose; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Manganese Poisoning; Parkinson Disease, Secondary; Raclopride; Salicylamides; Substantia Nigra; Tomography, Emission-Computed | 1995 |
Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.
Topics: Aged; Blood Glucose; Brain Mapping; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed | 1998 |
Nervous system dysfunction in Waldenström's macroglobulinemia: response to treatment.
Topics: Antibodies, Monoclonal; Bone Marrow Transplantation; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunoglobulin M; Male; Middle Aged; Myelin-Associated Glycoprotein; Neural Conduction; Parkinson Disease, Secondary; Peripheral Nervous System Diseases; Tomography, Emission-Computed; Waldenstrom Macroglobulinemia | 1998 |
The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
Topics: Aged; Apraxias; Basal Ganglia Diseases; Blood Glucose; Cerebral Cortex; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Muscle Rigidity; Nerve Degeneration; Neurologic Examination; Parkinson Disease, Secondary; Pyramidal Tracts; Tomography, Emission-Computed; Tremor | 1991 |
PET scanning in dystonia.
Topics: Adult; Aged; Brain; Cerebral Infarction; Deoxyglucose; Dystonia; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Parkinson Disease, Secondary; Reference Values; Tissue Distribution; Tomography, Emission-Computed; Torticollis | 1988 |
Clinical and acoustical variability in hypokinetic dysarthria.
Topics: Aged; Deoxyglucose; Dysarthria; Fluorine; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Phonation; Radioisotopes; Speech; Speech Acoustics; Speech Disorders; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1986 |